iotrolan has been researched along with Hemolysis in 2 studies
iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the complement-mediated assay, the dimer was approximately half as inhibitory of hemolysis as metrizamide or iopamidol." | 3.66 | Nonionic dimer: development and initial testing of an intrathecal contrast agent. ( Ranganathan, R; Sovak, M; Speck, U, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sovak, M | 1 |
| Ranganathan, R | 1 |
| Speck, U | 1 |
| Krause, W | 1 |
| Niehues, D | 1 |
2 other studies available for iotrolan and Hemolysis
| Article | Year |
|---|---|
Nonionic dimer: development and initial testing of an intrathecal contrast agent.
Topics: Animals; Central Nervous System; Contrast Media; Diencephalon; Eukaryota; Female; Hemolysis; Injecti | 1982 |
Biochemical characterization of x-ray contrast media.
Topics: 1-Butanol; Animals; Biochemical Phenomena; Biochemistry; Butanols; Chemical Precipitation; Complemen | 1996 |